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A psychiatric assistance dog (PAD) is a service dog that is trained to assist its handler (owner) who has 
been diagnosed with a mental health condition such as PTSD, depression, anxiety, or bipolar disorder. 
Little is known about the population of people who own PADs, the type of dogs used or the functions 
they provide. One third (n = 199) of PAD owners registered with the charity ‘mindDog’ (that assists 
people procure, train and certify PADs) participated in an online survey to explore these matters. 
Results show that owners have differing mental health diagnoses, and their dogs performed different 
tasks to support them in daily life. PAD usage decreased (46%), increased (30%) or did not change 
(24%) participants' use of psychiatric or other healthcare services. Decrease in service use was mainly 
due to reduced suicide attempts, and less requirement for hospitalisation and medication; increased 
use was mainly due to enhanced ability to attend appointments. Results also suggest that successful 
person-dog teams do not require the dog to have been bred, raised and trained for the role by 
assistance/service dog provider organisations. These findings will inform clients and medical 
professionals, who play a pivotal role regarding their patients’ application for a mindDog, about how 
dogs may be of assistance. 
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Background: Studies have shown Caucasian patients with inpatient hypoglycaemia are associated 
with increase in length of stay (LOS), mortality and cost. But there are no similar studies on indigenous 
Australians diabetic patients despite having higher prevalence of diabetes and its complications. The 
aim of the study was to evaluate pattern and outcomes of diabetic inpatient hypoglycemia among 
Aboriginal and Torres Strait Islander (ATSI) compared to Australian Caucasian patients. Method: A 
retrospective audit of diabetic patients aged >18 years admitted at The Townsville Hospital medical and 
surgical wards was analysed for a period between 1st April 2015 and 31st March 2016. The database 
contains clinical information at the time of admission and initial discharge and readmission within 4 
weeks thereafter. Results: 1618 (of total 6027) patients were admitted with diabetes representing 
23.7% of the total ward admissions of which 484 (29.9%) had inpatient hypoglycaemia.  Of the data 
analysed ATSI origin with inpatient hypoglycaemia was associated with longer length of stay (LOS) 
(HR=2.072, 95%CI: 1.219-3.485) while severe hypoglycaemia (<2.8 mmol/L) in both ATSI and non-
ATSI was significantly associated with longer LOS (HR: 1.878, 95CI%: 1.123-3.128). Conclusions: We 
reported high rate of inpatient hypoglycemia in our study population. Indigenous Australian diabetic 
patients with inpatient hypoglycemia had significantly longer LOS compared to non-Indigenous 
Caucasian counterparts. Over all our results are significant for promoting awareness of the effect of 
ethnic background on inpatient hypoglycemia risk. Further prospective studies on a larger population 
are needed to confirm our findings. 
  
